Zurich, Switzerland

Andreas Plueckthun

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Paul Scherrer Institut. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andreas Plueckthun. Retrieved from https://idiyas.com/inventor/andreas-plueckthun

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Andreas Plueckthun

Introduction

Andreas Plueckthun is a notable inventor based in Zurich, Switzerland. He is recognized for his contributions to the field of biochemistry, particularly in the development of therapeutic and diagnostic agents. His work has led to significant advancements in understanding protein interactions.

Latest Patents

Andreas Plueckthun holds a patent for the invention titled "DIbarnase-barstar complexes." This patent describes a complex comprising barnase bound with high affinity to barstar, which includes a therapeutic and/or diagnostic agent bound to either barnase or barstar. This innovation has potential applications in various medical fields.

Career Highlights

Throughout his career, Plueckthun has been associated with prestigious institutions such as the Paul Scherrer Institute and the University of Zurich. His work at these institutions has allowed him to explore and expand the boundaries of biochemistry and molecular biology.

Collaborations

Andreas Plueckthun has collaborated with notable colleagues, including Sergey Deyev and Robert Waibel. These collaborations have contributed to the advancement of research in protein engineering and therapeutic applications.

Conclusion

Andreas Plueckthun's innovative work and patent in the field of biochemistry highlight his significant contributions to science. His research continues to influence the development of new therapeutic and diagnostic methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…